Boehringer Ingelheim Venture Fund (CVC)

Offices: Rhineland-Palatinate (Germany), Cambridge (United States), Beijing (China)

Stages: Seed, Series A, Series B

Markets: Life Sciences, Health Care, BioTech, Digital Health (Immunomodulation, Tissue Regeneration, New Therapeutic Modalities, Microbiome, Patients Care Management, Medication Adherence, Digital Therapy)